ZALEPLON

NDC 57237-239 · Rising Pharma Holdings, Inc.

Generic nameZALEPLON

Dosage formCAPSULE

RouteORAL

Active ingredient(s)ZALEPLON

Strength5 mg/1

Pharmacologic classCentral Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]

DEA scheduleCIV

Marketing categoryANDA

Packages

57237-239-01 — 100 CAPSULE in 1 BOTTLE (57237-239-01)

FDA lists these products with the same active ingredient.

0054-0084 — Zaleplon, 0054-0085 — Zaleplon, 29300-131 — zaleplon, 29300-132 — zaleplon, 43063-505 — ZALEPLON, 43063-783 — zaleplon, 43063-912 — Zaleplon, 50090-1564 — zaleplon, 57237-240 — ZALEPLON, 63629-3405 — zaleplon, 65862-214 — ZALEPLON, 65862-215 — ZALEPLON, 68788-7208 — zaleplon, 68788-8725 — Zaleplon, 69452-364 — Zaleplon, 69452-365 — Zaleplon, 71335-0236 — zaleplon, 71335-1054 — ZALEPLON, 71335-2468 — Zaleplon

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.